{"id":"https://openalex.org/W1990950895","doi":"https://doi.org/10.1021/mp900306x","title":"ApoE3 Mediated Poly(butyl) Cyanoacrylate Nanoparticles Containing Curcumin: Study of Enhanced Activity of Curcumin against Beta Amyloid Induced Cytotoxicity Using In Vitro Cell Culture Model","display_name":"ApoE3 Mediated Poly(butyl) Cyanoacrylate Nanoparticles Containing Curcumin: Study of Enhanced Activity of Curcumin against Beta Amyloid Induced Cytotoxicity Using In Vitro Cell Culture Model","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-05","ids":{"openalex":"https://openalex.org/W1990950895","doi":"https://doi.org/10.1021/mp900306x","mag":"1990950895","pmid":"https://pubmed.ncbi.nlm.nih.gov/20230014"},"language":"en","primary_location":{"id":"doi:10.1021/mp900306x","doi":"https://doi.org/10.1021/mp900306x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp900306x","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990950895"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006163196","display_name":"Rohit S. Mulik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]},{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["GB","IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rohit S. Mulik","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland","institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020637669","display_name":"Jukka M\u00f6nkk\u00f6nen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]},{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["GB","IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jukka M\u00f6nkk\u00f6nen","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland","institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024765402","display_name":"Risto Olavi Juvonen","orcid":"https://orcid.org/0000-0001-9240-7673","observed_orcids":["https://orcid.org/0000-0001-9240-7673"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]},{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["GB","IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Risto O. Juvonen","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland","institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009422267","display_name":"Kakasaheb Ramoo Mahadik","orcid":"https://orcid.org/0000-0001-7622-6899","observed_orcids":["https://orcid.org/0000-0001-7622-6899"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]},{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["GB","IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kakasaheb R. Mahadik","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland","institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012634277","display_name":"Anant R. Paradkar","orcid":"https://orcid.org/0000-0003-1704-9858","observed_orcids":["https://orcid.org/0000-0003-1704-9858"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]},{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["GB","IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anant R. Paradkar","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune 411038, India, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, U.K., and Department of Pharmaceutics, and Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland","institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012634277"],"corresponding_institution_ids":["https://openalex.org/I139894009","https://openalex.org/I887998513"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.0516,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.89549839,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"7","issue":"3","first_page":"815","last_page":"825"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11319","display_name":"Curcumin's Biomedical Applications","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11319","display_name":"Curcumin's Biomedical Applications","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/curcumin","display_name":"curcumin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/apolipoprotein-e3","display_name":"apolipoprotein E3","score":0.9869999885559082},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.9200000166893005},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/photostability","display_name":"photostability","score":0.8679999709129333},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.49300000071525574},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.6669999957084656},{"id":"https://openalex.org/keywords/anti-apoptotic-effects","display_name":"anti-apoptotic effects","score":0.7720000147819519},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.8840000033378601},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2778250585","wikidata":"https://www.wikidata.org/wiki/Q312266","display_name":"Curcumin","level":2,"score":0.985650897026062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7412539124488831},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6893141865730286},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5982704758644104},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.5929223299026489},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5244891047477722},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.4509560167789459},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4494379460811615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11606857180595398},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003474","descriptor_name":"Curcumin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003474","descriptor_name":"Curcumin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004659","descriptor_name":"Enbucrilate","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053318","descriptor_name":"Apolipoprotein E3","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/mp900306x","doi":"https://doi.org/10.1021/mp900306x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp900306x","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:20230014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20230014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:bradscholars.brad.ac.uk:10454/6112","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10454/6112","pdf_url":null,"source":{"id":"https://openalex.org/S4306401846","display_name":"Bradford Scholars (University of Bradford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139894009","host_organization_name":"University of Bradford","host_organization_lineage":["https://openalex.org/I139894009"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322754","display_name":"Kansainv\u00e4lisen Liikkuvuuden ja Yhteisty\u00f6n Keskus","ror":"https://ror.org/00wj0f678"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W25396414","https://openalex.org/W1037500466","https://openalex.org/W1487727801","https://openalex.org/W1541649582","https://openalex.org/W1542215809","https://openalex.org/W1967579836","https://openalex.org/W1968786165","https://openalex.org/W1970101659","https://openalex.org/W1974008457","https://openalex.org/W1976194786","https://openalex.org/W1983963285","https://openalex.org/W1985229083","https://openalex.org/W1985859760","https://openalex.org/W1986166053","https://openalex.org/W1991936623","https://openalex.org/W2005397347","https://openalex.org/W2018121350","https://openalex.org/W2021876818","https://openalex.org/W2026218920","https://openalex.org/W2029552699","https://openalex.org/W2036220732","https://openalex.org/W2042610050","https://openalex.org/W2043011920","https://openalex.org/W2048695741","https://openalex.org/W2053607252","https://openalex.org/W2067038367","https://openalex.org/W2067531355","https://openalex.org/W2074772243","https://openalex.org/W2078389479","https://openalex.org/W2096693266","https://openalex.org/W2099826529","https://openalex.org/W2103440561","https://openalex.org/W2121515004","https://openalex.org/W2121892940","https://openalex.org/W2128635872","https://openalex.org/W2135824015","https://openalex.org/W2138684116","https://openalex.org/W2138955227","https://openalex.org/W2159879659","https://openalex.org/W2291454863","https://openalex.org/W2298612269"],"related_works":["https://openalex.org/W2060061127","https://openalex.org/W3006014613","https://openalex.org/W3046157327","https://openalex.org/W2613269927","https://openalex.org/W2022391347","https://openalex.org/W7127168136","https://openalex.org/W4402458275","https://openalex.org/W2316251591","https://openalex.org/W2005350078","https://openalex.org/W2771060125"],"abstract_inverted_index":{"Beta":[0,153],"amyloid":[1,28,31,141,154,235,251],"plays":[2],"a":[3,20,200],"main":[4],"role":[5],"in":[6,16,88,122,144,160,246,254],"the":[7,17,41,45,50,97,108,111,176,182,247],"pathophysiology":[8],"of":[9,47,72,94,110,113,117,137,166,184,208,249],"Alzheimer's":[10,255],"disease":[11],"by":[12,74,101],"inducing":[13],"oxidative":[14,33],"stress":[15],"brain.":[18],"Curcumin,":[19],"natural":[21],"antioxidant,":[22],"is":[23,155],"known":[24,156],"to":[25,65,125,149,157,191],"inhibit":[26],"beta":[27,30,140,234,250],"and":[29,38,68,87,199,210,221],"induced":[32,142,236,252],"stress.":[34],"However,":[35],"low":[36],"bioavailability":[37],"photodegradation":[39],"are":[40],"major":[42],"concerns":[43],"for":[44,80],"use":[46],"curcumin.":[48,127,240],"In":[49,128],"present":[51],"study,":[52],"we":[53],"have":[54,231],"formulated":[55],"apolipoprotein":[56],"E3":[57],"mediated":[58],"poly(butyl)":[59],"cyanoacrylate":[60],"nanoparticles":[61,77,98,123],"containing":[62],"curcumin":[63,73,95,118,151,167,185,193,211],"(ApoE3-C-PBCA)":[64],"provide":[66],"photostability":[67,116],"enhanced":[69,134,187,196],"cell":[70,130,197],"uptake":[71,198],"targeting.":[75],"Prepared":[76],"were":[78],"characterized":[79],"particle":[81],"size,":[82],"zeta":[83],"potential,":[84],"entrapment":[85,93],"efficiency":[86],"vitro":[89,129],"drug":[90,202],"release.":[91],"The":[92,115,205],"inside":[96],"was":[99,119,168,179,186,212,225],"confirmed":[100,107],"X-ray":[102],"diffraction":[103],"analysis.":[104],"Physicochemical":[105],"characterization":[106],"suitability":[109],"method":[112],"preparation.":[114],"increased":[120],"significantly":[121],"compared":[124,148,190],"plain":[126,150,192],"culture":[131],"study":[132],"showed":[133],"therapeutic":[135],"efficacy":[136],"ApoE3-C-PBCA":[138,189,242],"against":[139,233],"cytotoxicity":[143,237,253],"SH-SY5Y":[145],"neuroblastoma":[146],"cells":[147],"solution.":[152],"induce":[158],"apoptosis":[159],"neuronal":[161],"cells,":[162],"therefore":[163],"antiapoptotic":[164],"activity":[165,183,232],"studied":[169],"using":[170],"flow":[171],"cytometry":[172],"assays.":[173],"From":[174],"all":[175],"experiments,":[177],"it":[178],"found":[180,226],"that":[181,227],"with":[188,239],"solution":[194],"suggesting":[195],"sustained":[201],"release":[203],"effect.":[204],"synergistic":[206],"effect":[207],"ApoE3":[209,216,228],"also":[213,217],"studied,":[214],"since":[215],"possesses":[218],"both":[219],"antioxidant":[220],"antiamyloidogenic":[222],"activity.":[223],"It":[224],"did":[229],"indeed":[230],"along":[238],"Hence,":[241],"offers":[243],"great":[244],"advantage":[245],"treatment":[248],"disease.":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990950895","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
